Physician profile
Bussie A Evans
NPI 1407875073
$1,905.93
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $499 · 2021: $509 · 2022: $529 · 2023: $210 · 2024: $13.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $200.26 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $191.33 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $160.17 | 2019-2021 | |
| Amgen INC. | $150.67 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $147.93 | 2020-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.73 | 2020-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $129.68 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $101.07 | 2020-2023 | Xarelto |
| Abbott Laboratories | $87.45 | 2019-2023 | Ensite |
| Sanofi-Aventis U.S. LLC | $87.27 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.09 | 2021 | |
| Boston Scientific Corporation | $63.63 | 2022-2024 | Watchman Flx |
| Pfizer INC. | $62.73 | 2021-2022 | |
| Esperion Therapeutics, INC. | $56.20 | 2021 | |
| Abiomed | $54.77 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $50.21 | 2020-2021 | |
| Astellas Pharma US INC | $36.37 | 2021 | |
| Philips North America LLC | $34.31 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $22.67 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $20.35 | 2019 | |
| Medtronic Vascular, INC. | $19.16 | 2020 | |
| Alnylam Pharmaceuticals INC. | $15.74 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bussie Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.